Sean Duffy Sells 2,800 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 2,800 shares of the business’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $19.01, for a total transaction of $53,228.00. Following the completion of the sale, the chief executive officer directly owned 409,061 shares of the company’s stock, valued at $7,776,249.61. This represents a 0.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Omada Health Price Performance

NASDAQ OMDA traded up $1.99 during trading on Friday, hitting $20.89. 3,310,497 shares of the company’s stock traded hands, compared to its average volume of 946,807. The stock has a fifty day moving average of $16.51 and a two-hundred day moving average of $14.85. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92. The firm has a market cap of $1.24 billion and a P/E ratio of -77.37.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The firm had revenue of $78.05 million for the quarter. As a group, analysts expect that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have commented on OMDA. Morgan Stanley reiterated an “overweight” rating and issued a $30.00 price objective on shares of Omada Health in a research report on Monday. Weiss Ratings restated a “sell (e+)” rating on shares of Omada Health in a report on Thursday, June 4th. Wells Fargo & Company lifted their target price on shares of Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Needham & Company LLC reiterated a “buy” rating and set a $28.00 price target on shares of Omada Health in a report on Friday, May 8th. Finally, Citizens Jmp increased their price target on shares of Omada Health from $18.00 to $21.00 and gave the company a “market outperform” rating in a research report on Friday, May 8th. Ten investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Omada Health has an average rating of “Moderate Buy” and an average price target of $22.91.

Institutional Investors Weigh In On Omada Health

Several hedge funds have recently made changes to their positions in the company. Quarry LP bought a new stake in shares of Omada Health during the 4th quarter valued at $29,000. TD Waterhouse Canada Inc. bought a new stake in shares of Omada Health during the fourth quarter valued at approximately $32,000. Raymond James Financial Inc. bought a new stake in shares of Omada Health in the 2nd quarter worth $32,000. Inlight Wealth Management LLC purchased a new position in Omada Health in the 4th quarter worth about $45,000. Finally, Strs Ohio raised its holdings in shares of Omada Health by 151.0% during the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock valued at $67,000 after purchasing an additional 2,567 shares during the last quarter.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.